NCT00965263View on ClinicalTrials.gov

Therapeutic Cocaine Vaccine: Human Laboratory Study

PHASE2CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

March 31, 2003

Primary Completion Date

July 31, 2009

Study Completion Date

August 31, 2009

Conditions
Cocaine Dependence
Interventions
BIOLOGICAL

Cocaine vaccine (TA-CD)

TA-CD (82,360 μg; IM) were administered at weeks 1, 3, 5 and 9.

Trial Locations (1)

10032

New York-Presbyterian Hospital, New York

All Listed Sponsors
lead

New York State Psychiatric Institute

OTHER

NCT00965263 - Therapeutic Cocaine Vaccine: Human Laboratory Study | Biotech Hunter | Biotech Hunter